Indian Immunologicals Limited
Indian Immunologicals Limited (IIL), headquartered in Hyderabad, India, is a prominent player in the biotechnology and pharmaceutical industry. Founded in 1982, IIL has established itself as a leader in the production of vaccines and biopharmaceuticals, focusing on animal health and human health sectors. The company is renowned for its innovative range of products, including vaccines for livestock and poultry, as well as human vaccines. IIL's commitment to quality and research has led to significant milestones, such as the development of India's first indigenous rabies vaccine. With a strong market position, Indian Immunologicals Limited continues to contribute to public health and animal welfare, making it a trusted name in the immunological landscape.
DitchCarbon Score
How does Indian Immunologicals Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Indian Immunologicals Limited's score of 14 is lower than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Indian Immunologicals Limited's reported carbon emissions
Indian Immunologicals Limited, headquartered in India, currently does not report any specific carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established any documented reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. As a result, there is no information on their scope of emissions (Scope 1, 2, or 3) or any significant achievements in reducing carbon emissions. Without specific data or commitments, it is challenging to assess their climate impact or initiatives. In the absence of reported emissions and climate commitments, Indian Immunologicals Limited's approach to sustainability and carbon management remains unclear within the industry context.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Indian Immunologicals Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
